Clinical Trial Update: Genetic Effects on Dopamine Response to an Opiate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining genetic effects on dopamine response to an opiate; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Addiction
• Pain

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Polymorphism-Genetic, Pain | Phase 2 | Status: COMPLETED | Results posted: 2018-10-23